Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
A looming 20-1 reverse split will do that. They are going to list on NASDAQ after I believe.
VANCOUVER, British Columbia & DALLAS, July 29, 2024--(BUSINESS WIRE)--Alpha Cognition (CSE: ACOG) (OTCQB: ACOGF) (Alpha Cognition "ACI", or the "Company"), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, announces that the U.S. Food and Drug Administration (FDA) has granted approval for ZUNVEYL® (benzgalantamine) previously known as ALPHA-1062, for the treatment of mild-to-moderate Alzheimer's disease. Alzheimer’s disease (AD) is a progressive brain disorder that slowly destroys memory, thinking skills, and eventually the ability to do simple tasks, like carry on a conversation. AD is the most common form of dementia affecting nearly 7 million people, and is the leading cause of nursing home admissions and deaths, with 70% of all nursing home residents suffering with AD.
Hopefully, AVXL will join then soon.
It's almost as if having millions in lobbying money greases the wheels.
Load up on patches before this goes belly up.
I just got in a few days ago at 1.17 and sold today at 2.50, i may have jumped the gun. :( Now I have to hope for a pull back.
Blaming the China lockdowns is laughable. The problem is that they are not selling Actipatches, not a lack of products to sell. What does it matter if you produce a million units, but only sell 10k?
I'm considering buying 1.00 worth of shares at .0006 to remove the red blemish from my portfolio.
I just got kicked. I was able to get back on using another email address.
Phase 2b/3 ANAVEX®2-73 results complement and are consistent with findings from
the previously completed Alzheimer’s disease Phase 2a ANAVEX®2-73 trial, which
also demonstrated therapeutic effect on cognition and function over 148 weeks.
Consistent with patients treated for almost 3 years.
Lift that halt, I want to see if the market likes it.
Hopefully, this can move up after they raise cash.
I haven't listened to Cramer in 6-7 years. Did he have a stroke or something? His speech sounds slurred.
I hope Jeffery Toobin isn't on the video call.
Right on, Steve. Not keeping the website up to date is inexcusable. It is not hard or expensive. If you walk in to a restaurant and it dingy or dirty, you're first impression is not, "I want to eat here".
The Axome drug is also being tested for Alzheimer's agitation.
Hit Keith up on Twitter and leave questions.
I wonder if treating the insomnia would decrease Alzheimers's agitation.
tZERO has 6 stock on it's exchange right now. They use blockchain to identify shares. There can never be naked shares. Trades are settled at the time of purchase, no two days to settlement. This is the wave of the future. Who ultimately becomes the standard is anyone's guess.